Image

Global Selective Estrogen Receptor Degraders (SERD) Therapeutics Market - Industry Trends and Forecast to 2028

Pharmaceutical

Image

Global Selective Estrogen Receptor Degraders (SERD) Therapeutics Market - Industry Trends and Forecast to 2028

  • Pharmaceutical
  • Upcoming Report
  • Nov 2021
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Selective Estrogen Receptor Degraders (SERD) Therapeutics Market, By Type (Faslodex, GDC-9545, RAD1901, SAR439859, AZD9833, Others), Application (First-line Treatment, Second-line Treatment), End-Users (Clinic, Hospital, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), Country (U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa) Industry Trends and Forecast to 2028.

Selective Estrogen Receptor Degraders (SERD) Therapeutics Market

Market Analysis and Insights: Global Selective Estrogen Receptor Degraders (SERD) Therapeutics Market

Selective estrogen receptor degraders (SERD) therapeutics market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to account to grow at a CAGR of 16.66% in the above mentioned forecast period.

Selective estrogen receptor degraders (SERD) are the drugs that inhibit the estrogen receptor alpha or block the production of estrogen. They are effective in the treatment of metastatic breast cancer. Fulvestrant is the first and only SERD that has been clinically approved for the treatment of breast cancer.

Rising incidence of breast cancer, unmet clinical benefits with the existing treatment of breast cancer targeting hormone receptor-positive metastatic breast cancer, growing healthcare expenditure, use of oral drug delivery as advanced route of administration, limited dosage exposure, growing government and private funding for improved safety and outcomes provided by SERD therapy are the factors that will expand the selective estrogen receptor degraders (SERD) therapeutics market.

Rising focus of key players on the research and development activities for new product launch and increasing use of SERDs as combination therapy will provide beneficial opportunities for the selective estrogen receptor degraders (SERD) therapeutics market in the forecast period of 2021-2028.

However, resistance to endocrine therapy and high cost associated with the therapy are the factors that will hinder the market growth and will further challenge the SERD therapeutics market in the forecast period mentioned above.

This selective estrogen receptor degraders (SERD) therapeutics market  report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the selective estrogen receptor degraders (SERD) therapeutics market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Selective Estrogen Receptor Degraders (SERD) Therapeutics Market Scope and Market Size

The selective estrogen receptor degraders (SERD) therapeutics market is segmented on the basis of type, application, end-users and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

  • On the basis of type, the selective estrogen receptor degraders (SERD) therapeutics market is segmented into faslodex, GDC-9545, RAD1901, SAR439859, AZD9833 and others.
  • On the basis of application, the selective estrogen receptor degraders (SERD) therapeutics market is segmented into first-line treatment and second-line treatment.
  • On the basis of end-users, the selective estrogen receptor degraders (SERD) therapeutics market is segmented into clinic, hospital and others.

The selective estrogen receptor degraders (SERD) therapeutics market is also segmented on the basis of distribution channel into hospital pharmacy, retail pharmacy and online pharmacy.

Selective Estrogen Receptor Degraders (SERD) Therapeutics Market Country Level Analysis

Selective estrogen receptor degraders (SERD) therapeutics market is analyzed and market size information is provided by the country, type, application, end-users and distribution channel as referenced above.

The countries covered in the selective estrogen receptor degraders (SERD) therapeutics market  report are the U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa.

North America dominates the selective estrogen receptor degraders (SERD) therapeutics market due to the presence of major key players, growing incidence of breast cancer, relapse from existing endocrine therapies, high healthcare expenditure and well-developed healthcare sector in this region. Asia-Pacific is expected to grow during the forecast period of 2021-2028 due to the increasing research and development activities, rising investment in the healthcare sector and growing government support.

The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

Selective estrogen receptor degraders (SERD) therapeutics market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Competitive Landscape and Global Selective Estrogen Receptor Degraders (SERD) Therapeutics Market Share Analysis

Selective estrogen receptor degraders (SERD) therapeutics market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to selective estrogen receptor degraders (SERD) therapeutics market research.

The major players covered in the selective estrogen receptor degraders (SERD) therapeutics market report are AstraZeneca, Lilly, GlaxoSmithKline plc, F. Hoffmann-La Roche Ltd., Sanofi, Novartis AG, Sandoz International GmbH, Mylan N.V., Dr. Reddy’s Laboratories Ltd., Glenmark Pharmaceuticals Limited, Accord Healthcare, Teva Pharmaceutical Industries Ltd., Amneal Pharmaceuticals LLC, G1 Therapeutics, Inc., HBT Labs, Radius Health, Inc., Zenopharm, ZENTALIS PHARMACEUTICALS, among other domestic and global players.  Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo
Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials